These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21905944)

  • 41. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
    Lai CC; Hsu HL; Lee LN; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
    Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
    Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies.
    Hadrich I; Mary C; Makni F; Elloumi M; Dumon H; Ayadi A; Ranque S
    Med Mycol; 2011 Jul; 49(5):489-94. PubMed ID: 21108574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period.
    Zedek DC; Miller MB
    J Clin Microbiol; 2006 Apr; 44(4):1601. PubMed ID: 16597909
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
    Ahmad S; Khan ZU; Theyyathel AM
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.
    Fortún J; Martín-Dávila P; Alvarez ME; Norman F; Sánchez-Sousa A; Gajate L; Bárcena R; Nuño SJ; Moreno S
    Transplantation; 2009 Jan; 87(2):256-60. PubMed ID: 19155981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.
    Maertens J; Theunissen K; Verbeken E; Lagrou K; Verhaegen J; Boogaerts M; Eldere JV
    Br J Haematol; 2004 Sep; 126(6):852-60. PubMed ID: 15352990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
    Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
    Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory diagnosis of invasive aspergillosis.
    Hope WW; Walsh TJ; Denning DW
    Lancet Infect Dis; 2005 Oct; 5(10):609-22. PubMed ID: 16183515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.
    de Kruif MD; Gerritsen MG; van Haren EH; Bel EH; Jonkers RE
    Clin Respir J; 2017 Jul; 11(4):534-536. PubMed ID: 26364561
    [No Abstract]   [Full Text] [Related]  

  • 53. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications.
    Miceli MH; Maertens J; Buvé K; Grazziutti M; Woods G; Rahman M; Barlogie B; Anaissie EJ
    Cancer; 2007 Jul; 110(1):112-20. PubMed ID: 17525971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
    Orlopp K; von Lilienfeld-Toal M; Marklein G; Reiffert SM; Welter A; Hahn-Ast C; Purr I; Gorschlüter M; Molitor E; Glasmacher A
    J Antimicrob Chemother; 2008 Nov; 62(5):1109-12. PubMed ID: 18647743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy].
    Rácil Z; Mayer J; Kocmanová I; Wagnerová B; Winterová J; Folber F; Lengerová M; Moulis M; Zácková D; Smardová L; Janíková A; Navrátil M; Dvoráková D; Vorlícek J
    Vnitr Lek; 2008 Feb; 54(2):157-68. PubMed ID: 23687707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.
    Steinbach WJ; Addison RM; McLaughlin L; Gerrald Q; Martin PL; Driscoll T; Bentsen C; Perfect JR; Alexander BD
    Pediatr Infect Dis J; 2007 Jul; 26(7):558-64. PubMed ID: 17596794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galactomannan use in clinical practice: providing free testing is not the full answer.
    Dos Santos JS; Hermes DM; Pasqualotto AC
    Braz J Infect Dis; 2018; 22(1):37-40. PubMed ID: 29172032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Foy PC; van Burik JA; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):440-3. PubMed ID: 17287156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.